Kay NE - Search Results

1

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. Shanafelt TD, et al. Among authors: kay ne. J Clin Oncol. 2006 Oct 1;24(28):4634-41. doi: 10.1200/JCO.2006.06.9492. J Clin Oncol. 2006. PMID: 17008705

2

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.

Kay NE, Han L, Bone N, Williams G. Kay NE, et al. Br J Haematol. 2001 Mar;112(3):760-7. doi: 10.1046/j.1365-2141.2001.02605.x. Br J Haematol. 2001. PMID: 11260081 Free article.

3

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Jun;25(6):485-6. doi: 10.1016/s0145-2126(01)00008-x. Leuk Res. 2001. PMID: 11337021 No abstract available.

4

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Aug;25(8):709-10. doi: 10.1016/s0145-2126(01)00002-9. Leuk Res. 2001. PMID: 11397477 No abstract available.

5

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW. Fonseca R, et al. Among authors: kay ne. Leukemia. 2001 Jun;15(6):981-6. doi: 10.1038/sj.leu.2402125. Leukemia. 2001. PMID: 11417487 Clinical Trial.

6

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

Fonseca R, Harrington D, Oken MM, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Blood EA, Rajkumar SV, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Among authors: kay ne. Cancer Res. 2002 Feb 1;62(3):715-20. Cancer Res. 2002. PMID: 11830525

7

Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE. Jelinek DF, et al. Among authors: kay ne. Br J Haematol. 2001 Dec;115(4):854-61. doi: 10.1046/j.1365-2141.2001.03149.x. Br J Haematol. 2001. PMID: 11843819 Free article.

8

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Among authors: kay ne. Blood. 2002 May 15;99(10):3735-41. doi: 10.1182/blood.v99.10.3735. Blood. 2002. PMID: 11986230 Free article.

9

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

Kay NE, Bone ND, Tschumper RC, Howell KH, Geyer SM, Dewald GW, Hanson CA, Jelinek DF. Kay NE, et al. Leukemia. 2002 May;16(5):911-9. doi: 10.1038/sj.leu.2402467. Leukemia. 2002. PMID: 11986954

10

B-CLL: is the enigma of disease heterogeneity about to be revealed?

Kay NE, Jelinek DF. Kay NE, et al. Blood. 2002 Aug 15;100(4):1110-1. doi: 10.1182/blood.V100.4.1110b. Blood. 2002. PMID: 12149185 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters